中国高校科技期刊研究会第9次会员代表大会在北京召开，中宣部出版局副局长张怀海、教育部科学技术与信息化司一级巡视员张国辉等领导出席会议并发表..
英文简介：Biochemical Pharmacology publishes original research findings, Commentaries and review articles related to the elucidation of cellular and tissue function(s) at the biochemical and molecular levels, the modification of cellular phenotype(s) by genetic, transcriptional/translational or drug/compound-induced modifications, as well as the pharmacodynamics and pharmacokinetics of xenobiotics and drugs, the latter including both small molecules and biologics.The journal's target audience includes scientists engaged in the identification and study of the mechanisms of action of xenobiotics, biologics and drugs and in the drug discovery and development process.All areas of cellular biology and cellular, tissue/organ and whole animal pharmacology fall within the scope of the journal. Drug classes covered include anti-infectives, anti-inflammatory agents, chemotherapeutics, cardiovascular, endocrinological, immunological, metabolic, neurological and psychiatric drugs, as well as research on drug metabolism and kinetics. While medicinal chemistry is a topic of complimentary interest, manuscripts in this area must contain sufficient biological data to characterize pharmacologically the compounds reported. Submissions describing work focused predominately on chemical synthesis and molecular modeling will not be considered for review.While particular emphasis is placed on reporting the results of molecular and biochemical studies, research involving the use of tissue and animal models of human pathophysiology and toxicology is of interest to the extent that it helps define drug mechanisms of action, safety and efficacy.中文简介：（来自Google、百度翻译）生化药理学发表与阐明生化和分子水平上的细胞和组织功能，通过遗传，转录/翻译或药物/化合物引起的细胞表型修饰有关的原始研究发现，评论和评论文章-诱导修饰，以及外源生物和药物的药效学和药代动力学，后者包括小分子和生物制剂。 该杂志的目标受众包括从事鉴定和研究外源生物的作用机制的科学家，生物制品和药物以及药物的发现和开发过程。 细胞生物学和细胞，组织/器官和全动物药理学的所有领域都属于该杂志的范围。涵盖的药物类别包括抗感染药，抗炎剂，化学疗法，心血管，内分泌，免疫，代谢，神经和精神药物，以及药物代谢和动力学研究。虽然药物化学是一个值得关注的主题，但该领域的手稿必须包含足够的生物学数据，以在药理学上表征所报道的化合物。描述主要集中在化学合成和分子建模的工作的提交材料将不被考虑审查。 虽然特别强调报告分子和生化研究的结果，涉及使用人类病理生理学和毒理学的组织和动物模型的研究在一定程度上有助于定义药物作用，安全性和有效性。
